DE3870016D1 - Mischungen polarer und neutraler lipide zur protektion des magen-darm-traktes. - Google Patents

Mischungen polarer und neutraler lipide zur protektion des magen-darm-traktes.

Info

Publication number
DE3870016D1
DE3870016D1 DE8888301336T DE3870016T DE3870016D1 DE 3870016 D1 DE3870016 D1 DE 3870016D1 DE 8888301336 T DE8888301336 T DE 8888301336T DE 3870016 T DE3870016 T DE 3870016T DE 3870016 D1 DE3870016 D1 DE 3870016D1
Authority
DE
Germany
Prior art keywords
mixtures
neutral lipids
compositions
saturated
stomestyle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888301336T
Other languages
English (en)
Inventor
Lenard M Lichtenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Application granted granted Critical
Publication of DE3870016D1 publication Critical patent/DE3870016D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE8888301336T 1987-02-17 1988-02-17 Mischungen polarer und neutraler lipide zur protektion des magen-darm-traktes. Expired - Lifetime DE3870016D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/015,394 US4918063A (en) 1987-02-17 1987-02-17 Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract

Publications (1)

Publication Number Publication Date
DE3870016D1 true DE3870016D1 (de) 1992-05-21

Family

ID=21771153

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888301336T Expired - Lifetime DE3870016D1 (de) 1987-02-17 1988-02-17 Mischungen polarer und neutraler lipide zur protektion des magen-darm-traktes.

Country Status (8)

Country Link
US (1) US4918063A (de)
EP (1) EP0287198B1 (de)
JP (1) JP2820688B2 (de)
AT (1) ATE74758T1 (de)
CA (1) CA1310909C (de)
DE (1) DE3870016D1 (de)
ES (1) ES2038285T3 (de)
GR (1) GR3004396T3 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
JP3691054B2 (ja) * 1992-01-16 2005-08-31 ボード、オブ、リージェンツ、ザ、ユニバーシティー、オブ、テキサス、システム 癌の治療におけるカロチノイド類の処方及び用法
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
ES2219871T3 (es) * 1997-02-21 2004-12-01 Abbott Laboratories Procedimiento y composiciones que sirven para limitar la frecuencia de la enterocolitis necrotizante del recien nacido.
US7413759B2 (en) * 1998-05-21 2008-08-19 Beech-Nut Nutrition Corporation Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
US6579551B1 (en) 1998-05-21 2003-06-17 Beech-Nut Nutrition Corporation Baby-food compositions containing egg yolk and methods therefor
US7141266B2 (en) * 1998-05-21 2006-11-28 Beech-Nut Nutrition Corporation Baby-food compositions enhancing visual acuity and methods therefor
US6149964A (en) * 1998-05-21 2000-11-21 Beech-Nut Nutrition Corporation Egg yolk-containing baby food compositions and methods therefor
ATE305235T1 (de) 1998-12-22 2005-10-15 Unilever Nv Kosmetische verwendung von petroselinsäure
WO2001076577A2 (en) 2000-04-07 2001-10-18 The Board Of Regents Of The University Of Texas System Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
US20080051373A1 (en) * 2003-07-31 2008-02-28 The Board Of Regents Of The University Of Texas System Parenteral preparations of GI-safer phospholipid-associated anti-inflammatories and methods of preparation and use
WO2005027933A1 (en) * 2003-09-23 2005-03-31 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Unsaturated phosphatidylcholines and uses thereof
ATE470435T1 (de) * 2003-11-03 2010-06-15 Yissum Res Dev Co Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set
CN102988373A (zh) * 2006-07-19 2013-03-27 德克萨斯大学系统董事会 用于治疗炎性肠病的磷脂与含有5-氨基水杨酸之药物的制备物
EP2172203A1 (de) * 2008-09-17 2010-04-07 Giuliani S.P.A. Pharmazeutisches Zusammensetzung zur Behandlung von Magen-Darm-Reizungsstörungen
US8471047B1 (en) * 2010-12-09 2013-06-25 Surfatech Corporation Mixed glyceryl esters
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
EP2848251B1 (de) * 2013-09-12 2017-04-19 King Saud University Auszüge und isolierte Verbindungen von Cakile arabica für die Behandlung von Geschwüren
WO2021195319A1 (en) 2020-03-26 2021-09-30 Plx Opco Inc. PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND- METHODS FOR MAKING AND USING SAME
CN112516129B (zh) * 2021-01-09 2022-04-29 兰州大学 反式1,3-二亚油精在制备治疗胃癌药物、健胃药物、保健品和食品中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556592C2 (de) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittelzubereitungen auf Basis öliger Lösungen von Phospholipiden
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung
DE3028074C2 (de) * 1980-07-22 1983-12-08 Kurt Kampffmeyer Mühlenvereinigung KG, 2000 Hamburg Verfahren zur Herstellung eines lecithinhaltigen Produktes
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
EP0092121B1 (de) * 1982-04-12 1987-12-16 Board Of Regents, The University Of Texas System Verfahren und Zusammensetzungen zur Behandlung von Magen- und Darm-Ulcus
DE3369644D1 (en) * 1982-11-22 1987-03-12 Teijin Ltd Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
DE3346525C2 (de) * 1983-12-22 1987-03-19 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
CA1296640C (en) * 1985-07-26 1992-03-03 Meir Shinitzky Special lipid mixture for membrane fluidization

Also Published As

Publication number Publication date
ATE74758T1 (de) 1992-05-15
JP2820688B2 (ja) 1998-11-05
JPS63301824A (ja) 1988-12-08
EP0287198A3 (en) 1988-11-17
ES2038285T3 (es) 1993-07-16
EP0287198B1 (de) 1992-04-15
US4918063A (en) 1990-04-17
EP0287198A2 (de) 1988-10-19
CA1310909C (en) 1992-12-01
GR3004396T3 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
DE3870016D1 (de) Mischungen polarer und neutraler lipide zur protektion des magen-darm-traktes.
CA2003692A1 (en) Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract and additional applications for surfactant replacement therapy and other conditions requiring rapid phospholipid _absorption to surfaces
BR8007609A (pt) Extrator cirurgico para extirpar corpos estranhos atraves das vias naturais do corpo humano
ATE106867T1 (de) 13-trans-retinsäureester.
ATE226437T1 (de) (phospho)lipide zum bekämpfen einer hepatitis b- infektion
ATE174795T1 (de) Verfahren zur regulierung der sexuellen reaktion beim menschen
BR8103790A (pt) Aparelho para tratamento com oxigenio hiperbarico
SE8001685L (sv) Karcinostatiskt och immunostimulerande medel innehallande lysofosfolipid och fosfolipid och forfarande for framstellning derav
NO160579C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-(1,4,5-trifenylimidazol-2-yloksy)-alkansyrer og disses derivater.
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
BE858585A (fr) Purification des huiles par addition de phosphatides hydratables
ES2118629T3 (es) Mezcla de grasas conteniendo fosfolipidos con acidos grasos lcp
DE69319338D1 (de) Einfach ungesättigte fette als nahrungszusätze zur minimierung der folgen katabolischer erkrankungen
NO870397D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser.
IT1206973B (it) Procedimento continuo e apparecchio per la sbianca di oli trigliceridi ci con adsorbenti
ES505291A0 (es) Procedimiento para la preparacion de esteres de acidos car- boxilicos insaturados
FI845019A0 (fi) Farmaceutiskt preparat foer behandling av reumatiska sjukdomar.
AR231546A1 (es) Procedimiento modular para producir negros de humo de horno que tienen areas superficiales aumentadas
MX6274E (es) Procedimiento para la preparacion de composiciones parmaceuticas que contienen alcohilantes citostaticos destoxificados
ES535091A0 (es) Procedimiento de obtencion de una fraccion de hidrocarburos a partir de cera de abeja.
NL7604937A (nl) Werkwijze voor het afzinken van grote onder- delen evenals afgezonken constructie verkregen onder toepassing van de werkwijze.
COLLIN et al. AALBERG, JEFFREY, 168 ALLISON, AC, 94
NO141729C (no) Fremgangsmaate til holografisk behandling av boelger
SE8206842L (sv) Medel for behandling av akne
SU643158A1 (ru) Физиотерапевтическое устройство

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee